It feels weird to share happy news when everything around me is melting, but here we go… I am proud to be named a 2025 ASH Scholar🩸♥️ I am thankful for supportive mentors, colleagues, and lab members who helped me make this goal reality. tinyurl.com/y832hjs5

Really excited to visit Molecular Microbiology and Immunology at JHSPH and share some of our unpublished findings about the noncanonical inflammasomes!

🧬✨ Dr. Basu (Devraj Basu, MD, PhD, FACS) led the creation of the HPV+ Head & Neck Cancer Translational Center of Excellence at Penn’s Abramson Cancer Center (Penn Medicine - Abramson Cancer Center), advancing biomarker research & personalized therapies to improve patient outcomes. 🔗 Read more: loom.ly/f8g5aMs

SITC would like to extend our gratitude towards the Sparkathon Class of 2025! It was a successful program on Cellular Therapy for Solid Tumors. We look forward to meeting again @ SITC's 40th Anniversary Annual Meeting & Pre-Conference Programs! #Sparkathon sitcancer.org/2025

Honored to be selected for the SITC Sparkathon Class of 2025 towards the independence and to receive the 'Best Work Addressing Unmet Need' award for my cancer immunotherapy research. Grateful for the mentorship of Dr. Carl June. #Sparkathon Society for Immunotherapy of Cancer

Hot off the press from the Devraj Basu, MD, PhD, FACS at Penn Medicine Penn Otorhinolaryngology. One of many to come and leveraging one of the largest HPV+ oropharyngeal cancer patient cohorts in the U.S.

ft. M. Sannigrahi, L. Raghav, D. Rich, J. You, R. Brody, Ahmed Diab, Devraj Basu, MD, PhD, FACS (Penn Otorhinolaryngology), John Lukens, A. Lin (Penn Radiation Oncology Residency), Lova Sun, R. Cohen (Penn Medicine - Abramson Cancer Center), E. Brown (Univ. of Pennsylvania Department of Cancer Biology), P. Gimotty & J. Jalaly (Penn Path & Lab Medicine) Penn Microbiology academic.oup.com/jnci/advance-a…

Proud of my growing team at UPenn — united by one mission: to cure prostate cancer using novel, engineered CAR T cells. Grateful to my mentor Dr. Carl June Carl June for trusting me to lead a team of brilliant, motivated scientists! Penn Medicine Prostate Cancer Foundation

Excited to share our latest study in Biochemical Journal! We identified a novel SPOP degron in MyD88 and other substrates, featuring a new N-terminal Q-motif essential for SPOP-mediated degradation. These insights could help identify new SPOP substrates. portlandpress.com/biochemj/artic…

🚨Finally! Ravi Uppaluri, MDPhD presents data from Keynote0689 -- anti-PD1 makes it in locally advanced HNSCC -- approximate 10% EFS benefit from Pembro in surgically managed HNSCC. #aacr25 #hncsm

Job alert! We are looking for postdoc interested in quantitative methods to understand metabolic programming in cancer and immune cells! Also recruiting technician to help manage lab instruments and projects. DM or email me or forward to anyone you think that might be interested!

The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research. Meet this year’s class: bit.ly/YIAwardsClass2… #ProstateCancer #MedEd #MedX

Congrats to E. John Wherry, PhD, Co-Director of the PICI Center at Penn Medicine, on his election to the National Academy of Sciences—one of the highest honors in American science! His discoveries in T cell exhaustion and checkpoint pathways have transformed cancer immunotherapy and continue to

AHNS So proud of this tribute to my dear friend Dr. Eddie Mendez. His profound legacy lives on through the work of these fellows and our society!

Thanks to NIH-supported research, baby KJ successfully received personalized gene therapy treatment for CPS1, a life-threatening, incurable genetic disease. This marks the first time this technology has been successfully used to treat a human patient.

Boom!💥 ⁦FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. fda.gov/drugs/resource…

📢 Just Published! Dr. Douglas’s latest research reveals how chemotherapy-induced taste changes impact nutrition and quality of life. 🔗 Read More: loom.ly/jUJKxfc (#linkinbio) #CancerResearch #SmellandTaste #QualityOfLife #NutritionMatters #Rhinology

Proud of my student, Jidapa Janpathompong, for delivering an outstanding presentation on her summer research at the SUIP Symposium at Penn. Huge thanks to everyone who made this event a success! Research Trainee Affairs at Penn Medicine Parker Institute for Cancer Immunotherapy Penn Medicine Donita Brady of Brady Lab UPenn

What's the difference between Trm and exhausted CD8 T cells? Simone Park's new work dissects this important question. These cell types are often confused, but are ontologically and mechanistically distinct with implications for immunotherapy responses. biorxiv.org/content/10.110…

Please Repost: 3 out of 4 adults by age 30 have HPV. In the past 4 years HPV related tongue, throat & tonsil cancer has surpassed cervical cancer & become an epidemic among men between ages 40-60. Let's protect our sons and daughter by leaning about the HPV vaccine. Zainab Shinkafi-Bagudu